Search

Search Results
Results 5771 - 5780 of 6156 for light therapy
  • Humira
    Drug - 31 Oct 2024
    Consumer Medicine Information (CMI) about Humira intended for persons living in Australia.
  • DBL Vincristine Sulfate Injection
    Drug - 24 Oct 2024
    Consumer Medicine Information (CMI) about DBL Vincristine Sulfate Injection (Vincristine Sulfate) intended for persons living in Australia.
  • Vincristine Sulfate Injection
    Drug - 23 Oct 2024
    Consumer Medicine Information (CMI) about Vincristine Sulfate Injection (Vincristine Sulfate) intended for persons living in Australia.
  • Xeljanz
    Drug - 18 Oct 2024
    Consumer Medicine Information (CMI) about Xeljanz intended for persons living in Australia.
  • Symbicort Rapihaler
    Drug - 16 Oct 2024
    Consumer Medicine Information (CMI) about Symbicort Rapihaler intended for persons living in Australia.
  • Symbicort Turbuhaler
    Drug - 16 Oct 2024
    Consumer Medicine Information (CMI) about Symbicort Turbuhaler intended for persons living in Australia.
  • Rilast Turbuhaler
    Drug - 16 Oct 2024
    Consumer Medicine Information (CMI) about Rilast Turbuhaler intended for persons living in Australia.
  • Rilast Rapihaler
    Drug - 16 Oct 2024
    Consumer Medicine Information (CMI) about Rilast Rapihaler intended for persons living in Australia.
  • DBL Dexamethasone Sodium Phosphate
    Drug - 14 Oct 2024
    Consumer Medicine Information (CMI) about DBL Dexamethasone Sodium Phosphate (Dexamethasone Phosphate) intended for persons living in Australia.
  • Cell therapies and immune system rebalancing
    White Paper - 9 Oct 2024
    Cell therapies are revolutionizing autoimmune disease treatment by assisting immune system rebalancing.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback